Trial intelligence / Profile preview

Inhaled Isopropyl Alcohol for Nausea at EDM Festivals

NCT04307550Completed

Start
Jul 2021
Primary completion
Oct 2024
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of Isopropyl alcohol in nausea ((none)) (2 arms). Primary endpoint: Self-reported nausea at 10 months. Started Jul 2021; status: completed.

02

Drugs

Isopropyl alcohol
03

Conditions

nausea ((none))

Beyond the preview

Go deeper on NCT04307550.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04307550.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call